News Formal

U.S. drugmaker earnings heat up this week with spotlight on vaccine news

  • 📰 Reuters
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

इंडिया समाचार समाचार

इंडिया ताज़ा खबर,इंडिया मुख्य बातें

Several major U.S. drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc , Merck & Co and others on their efforts to develop vaccines and therapies against the novel coronavirus.

Globally, drugmakers are expected to increase second-quarter earnings per share by 2%, after they rose 17% in the first quarter, according to Cowen & Co.

Pfizer, which has released early data on its vaccine candidate being developed with German biotech BioNTech SE , will kick off the week of drugmaker earnings on Tuesday morning. Gilead’s antiviral treatment, remdesivir, has become a key weapon for many countries after the intravenously administered medicine helped shorten hospital recovery times in a U.S. trial.

 

आपकी टिप्पणी के लिए धन्यवाद। आपकी टिप्पणी समीक्षा के बाद प्रकाशित की जाएगी।

Well, I never expected that ! 🤑

Hey Democrats! Here, money to redistribute! *crickets*

Don’t need it, Doc on steps has a cure.

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

 /  🏆 2. in İN

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

US stocks rise as tech trades higher, investors await stimulus bill | Markets InsiderUS stocks rose on Monday as investors looked to major earnings on deck this week and awaited the release of the GOP's coronavirus stimulus plan.... Meanwhile, their customers are getting screwed.
स्रोत: BusinessInsider - 🏆 729. / 51 और पढो »